Skip to main content

Share story

Policy

White House reportedly drafts NIH grant veto power for OMB chief

Image of a bald man with a beard and glasses. Image: Primary
The Trump administration is drafting an executive order that would give Office of Management and Budget Director Russell Vought veto power over every individual National Institutes of Health grant, Ars Technica reported, citing reporting by The Washington Post, The New York Times and Politico. The change would place a political appointee directly in the approval path for funding from the NIH's $47 billion budget. NIH grants support university research ranging from basic biology to clinical trials. The order remains a draft; earlier administration efforts to terminate grants or impose politically driven funding rules were blocked by a court or Congress.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Ars Technica and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

Security
Security

Gyazo breach exposed metadata for 490 million images

A breach at screenshot-sharing service Gyazo exposed nearly 24 million customer records and an additional 490 million image-metadata records, Infosecurity Magazine reported. Attackers exploited an upload-server vulnerability, gain...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...